Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors
Sotio Biotech Inc.
Sotio Biotech Inc.
M.D. Anderson Cancer Center
Tempus AI
Palleon Pharmaceuticals, Inc.
Incyte Corporation
MacroGenics
Duke University
NRG Oncology
Kymab Limited
Stanford University
Astellas Pharma Inc
National Cancer Institute (NCI)
Novartis
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Pfizer
Pfizer
ADC Therapeutics S.A.
Exelixis
Eli Lilly and Company
NextCure, Inc.
Eisai Inc.
Hoffmann-La Roche
Nektar Therapeutics
Nektar Therapeutics
Herlev Hospital
Milton S. Hershey Medical Center
Ludwig Institute for Cancer Research
Ludwig Institute for Cancer Research
Incyte Corporation
Novartis
Duke University
National Institutes of Health Clinical Center (CC)
Incyte Corporation
EMD Serono
Novartis
Incyte Corporation
National Institutes of Health Clinical Center (CC)
Abramson Cancer Center at Penn Medicine
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Eli Lilly and Company
DEKK-TEC, Inc.
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
University of California, San Francisco
Icahn School of Medicine at Mount Sinai
Beth Israel Deaconess Medical Center
EMD Serono
Memorial Sloan Kettering Cancer Center
Merck Sharp & Dohme LLC
INSYS Therapeutics Inc